AGP Franklin LLC Takes $3.07 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

AGP Franklin LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 6,072 shares of the healthcare conglomerate’s stock, valued at approximately $3,072,000. UnitedHealth Group makes up approximately 1.9% of AGP Franklin LLC’s investment portfolio, making the stock its 15th biggest position.

Other institutional investors have also modified their holdings of the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $25,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $28,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group during the 4th quarter worth about $30,000. Finally, Promus Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at about $32,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

UNH opened at $586.23 on Tuesday. The firm has a market capitalization of $536.23 billion, a PE ratio of 37.82, a PEG ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $438.50 and a twelve month high of $630.73. The firm’s 50-day moving average price is $513.80 and its 200 day moving average price is $541.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 earnings per share. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on UNH. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Mizuho lifted their price target on UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, April 9th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Twenty-one equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $632.85.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.